Liraglutide add-on to metformin improves postprandial glucose control compared with metformin monotherapy in patients with Type 2 diabetes: posthoc analysis of the Liraglutide Effect and Action in Diabetes (LEAD)2 study

被引：0
|
作者：
Stephens, J. W. [1 ]
Fulcher, G. [2 ]
Matthews, D. R. [3 ]
Nauck, M. A. [4 ]
Svendsen, C. B. [5 ]
Donsmark, M. [5 ]
Garber, A. [6 ]
机构：
[1] Swansea Univ, Coll Med, Swansea, W Glam, Wales
[2] Northern Clin Sch, Sydney, NSW, Australia
[3] Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England
[4] Diabeteszentrum, Bad Lauterberg im Harz, Germany
[5] Novo Nordisk AS, Med Affairs, Liraglutide Diabet, Soborg, Denmark
[6] Baylor Coll Med, Houston, TX 77030 USA
来源：
DIABETIC MEDICINE | 2014年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：178 / 178
页数：1
相关论文
共 50 条
  • [1] Add-On Treatment with Liraglutide Improves Glycemic Control in Patients with Type 2 Diabetes on Metformin Therapy
    Chiefari, Eusebio
    Capula, Carmelo
    Vero, Ada
    Oliverio, Rosa
    Puccio, Luigi
    Liguori, Rossella
    Pullano, Vittorio
    Greco, Manfredi
    Foti, Daniela
    Tirinato, Domenico
    Vero, Raffaella
    Brunetti, Antonio
    DIABETES TECHNOLOGY & THERAPEUTICS, 2015, 17 (07) : 468 - 474
  • [2] Greater postprandial glucose control across all three daily meals with liraglutide compared with placebo when added to metformin and rosiglitazone in patients with Type 2 diabetes: posthoc analysis of Liraglutide Effect and Action on Diabetes (LEAD)4
    Bain, S. C.
    Shomali, M.
    Blonde, L.
    Svendsen, C. B.
    Thomsen, H.
    Zinman, B.
    DIABETIC MEDICINE, 2014, 31 : 177 - 177
  • [3] Liraglutide significantly improves glycemic control and reduces body weight compared with glimepiride as add-on to metformin in type 2 diabetes
    Nauck, MA
    Hompesch, M
    Filipczak, R
    Le, TDT
    Nielsen, L
    Zdravkovic, M
    Gumprecht, J
    DIABETES, 2004, 53 : A83 - A83
  • [4] Cost-utility analysis of liraglutide compared with sulphonylurea or sitagliptin, all as add-on to metformin monotherapy in Type 2 diabetes mellitus
    Davies, M. J.
    Chubb, B. D.
    Smith, I. C.
    Valentine, W. J.
    DIABETIC MEDICINE, 2012, 29 (03) : 313 - 320
  • [5] Liraglutide improves treatment satisfaction in people with Type 2 diabetes compared with sitagliptin, each as an add on to metformin
    Davies, M.
    Pratley, R.
    Hammer, M.
    Thomsen, A. B.
    Cuddihy, R.
    DIABETIC MEDICINE, 2011, 28 (03) : 333 - 337
  • [6] Efficacy and Safety Comparison of Liraglutide, Glimepiride, and Placebo, All in Combination With Metformin, in Type 2 Diabetes The LEAD (Liraglutide Effect and Action in Diabetes)-2 study
    Nauck, Michael
    Frid, Anders
    Hermansen, Kjeld
    Shah, Nalini S.
    Tankova, Tsvetalina
    Mitha, Ismail H.
    Zdravkovic, Milan
    During, Maria
    Matthews, David R.
    DIABETES CARE, 2009, 32 (01) : 84 - 90
  • [7] Liraglutide as add-on to metformin in type 2 diabetes: significant improvement in glycaemic control with a reduction in body weight compared with glimepiride
    Nauck, M
    Hompesch, N
    Filipczak, R
    Le, TTD
    Nielsen, L
    Zdravkovic, M
    Gumprecht, J
    DIABETOLOGIA, 2004, 47 : A281 - A281
  • [8] COST-UTILITY ANALYSIS OF LIRAGLUTIDE VERSUS GLIMEPIRIDE AS ADD-ON TO METFORMIN IN TYPE 2 DIABETES PATIENTS IN CHINA
    Gao, Lan
    Zhao, Fei-Li
    Li, Shu-Chuen
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2012, 28 (04) : 436 - 444
  • [9] COST-UTILITY ANALYSIS OF LIRAGLUTIDE VERSUS GLIMEPIRIDE AS ADD-ON TO METFORMIN IN PATIENTS WITH TYPE 2 DIABETES IN CHINA
    Gao, L.
    Li, S. C.
    VALUE IN HEALTH, 2012, 15 (07) : A663 - A663
  • [10] Efficacy and safety of liraglutide monotherapy compared With metformin in Japanese overweight/obese patients with type 2 diabetes
    Tanaka, Kumiko
    Saisho, Yoshifumi
    Kawai, Toshihide
    Tanaka, Masami
    Meguro, Shu
    Irie, Junichiro
    Imai, Takatoshi
    Shigihara, Toshikatsu
    Morimoto, Jiro
    Yajima, Ken
    Atsumi, Yoshihito
    Takei, Izumi
    Itoh, Hiroshi
    ENDOCRINE JOURNAL, 2015, 62 (05) : 399 - 409
12345